GO ID | GO:0005576 |
Ontology | CC |
GO Term | extracellular region |
Definition | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
VWA8 |
von Willebrand factor A domain containing 8 |
23078 |
A3KMH1 |
chr13: 41,566,837-41,961,120 |
IGIP |
IgA-inducing protein |
492311 |
A6NJ69 |
chr5: 140,125,935-140,129,392 |
MASP2 |
mannan-binding lectin serine peptidase 2 |
10747 |
O00187 |
chr1: 11,026,523-11,047,233 |
TNFRSF11B |
tumor necrosis factor receptor superfamily member 11b |
4982 |
O00300 |
chr8: 118,923,557-118,952,200 |
RNASET2 |
ribonuclease T2 |
8635 |
O00584 |
chr6: 166,929,504-166,957,191 |
ISLR |
immunoglobulin superfamily containing leucine-rich repeat |
3671 |
O14498 |
chr15: 74,173,671-74,176,872 |
NCAN |
neurocan |
1463 |
O14594 |
chr19: 19,211,973-19,252,233 |
PRRG1 |
proline rich Gla (G-carboxyglutamic acid) 1 |
5638 |
O14668 |
chrX: 37,349,275-37,457,295 |
TNFSF11 |
tumor necrosis factor superfamily member 11 |
8600 |
O14788 |
chr13: 42,562,736-42,608,013 |
EREG |
epiregulin |
2069 |
O14944 |
chr4: 74,365,143-74,388,751 |
PDZD2 |
PDZ domain containing 2 |
23037 |
O15018 |
chr5: 31,639,410-32,110,931 |
SEMA3E |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
9723 |
O15041 |
chr7: 83,363,906-83,649,010 |
NPC1 |
Niemann-Pick disease, type C1 |
4864 |
O15118 |
chr18: 23,506,184-23,586,898 |
ANGPT2 |
angiopoietin 2 |
285 |
O15123 |
chr8: 6,499,651-6,563,409 |
ADAM12 |
ADAM metallopeptidase domain 12 |
8038 |
O43184 |
chr10: 126,012,381-126,388,455 |
KLK10 |
kallikrein related peptidase 10 |
5655 |
O43240 |
chr19: 51,012,739-51,020,175 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
10653 |
O43291 |
chr19: 38,244,035-38,292,614 |
ACTN4 |
actinin, alpha 4 |
81 |
O43707 |
chr19: 38,647,649-38,731,583 |
CALU |
calumenin |
813 |
O43852 |
chr7: 128,739,292-128,771,807 |
CD5L |
CD5 molecule like |
922 |
O43866 |
chr1: 157,830,914-157,898,256 |
NRP2 |
neuropilin 2 |
8828 |
O60462 |
chr2: 205,681,990-205,798,133 |
FCMR |
Fc fragment of IgM receptor |
9214 |
O60667 |
chr1: 206,904,386-206,923,247 |
ADAM23 |
ADAM metallopeptidase domain 23 |
8745 |
O75077 |
chr2: 206,443,539-206,621,130 |
WDR1 |
WD repeat domain 1 |
9948 |
O75083 |
chr4: 10,074,339-10,116,949 |
TULP3 |
tubby like protein 3 |
7289 |
O75386 |
chr12: 2,877,223-2,941,140 |
CA11 |
carbonic anhydrase XI |
770 |
O75493 |
chr19: 48,637,942-48,646,312 |
LRP6 |
LDL receptor related protein 6 |
4040 |
O75581 |
chr12: 12,116,025-12,267,012 |
TNFSF13 |
tumor necrosis factor superfamily member 13 |
8741 |
O75888 |
chr17: 7,558,292-7,561,608 |
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
SLIT2 |
slit guidance ligand 2 |
9353 |
O94813 |
chr4: 20,253,260-20,620,561 |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
22943 |
O94907 |
chr10: 52,314,296-52,318,042 |
NXPH3 |
neurexophilin 3 |
11248 |
O95157 |
chr17: 49,575,858-49,583,827 |
CSPG5 |
chondroitin sulfate proteoglycan 5 |
10675 |
O95196 |
chr3: 47,562,239-47,580,792 |
BMP10 |
bone morphogenetic protein 10 |
27302 |
O95393 |
chr2: 68,865,481-68,871,517 |
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
IL33 |
interleukin 33 |
90865 |
O95760 |
chr9: 6,215,786-6,257,983 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
30008 |
O95967 |
chr11: 65,866,441-65,873,592 |
F8 |
coagulation factor VIII, procoagulant component |
2157 |
P00451 |
chrX: 154,835,788-155,026,940 |
F13A1 |
coagulation factor XIII, A1 polypeptide |
2162 |
P00488 |
chr6: 6,144,085-6,321,013 |
F2 |
coagulation factor II (thrombin) |
2147 |
P00734 |
chr11: 46,719,180-46,739,506 |
C1R |
complement component 1, r subcomponent |
715 |
P00736 |
chr12: 7,080,209-7,092,607 |
HP |
haptoglobin |
3240 |
P00738 |
chr16: 72,054,592-72,061,055 |
PLG |
plasminogen |
5340 |
P00747 |
chr6: 160,702,238-160,753,315 |
PLAU |
plasminogen activator, urokinase |
5328 |
P00749 |
chr10: 73,909,177-73,917,497 |
PLAT |
plasminogen activator, tissue |
5327 |
P00750 |
chr8: 42,175,233-42,207,724 |
CFB |
complement factor B |
629 |
P00751 |
chr6: 31,945,650-31,952,084 |
SERPINC1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
462 |
P01008 |
chr1: 173,903,804-173,917,378 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
5265 |
P01009 |
chr14: 94,376,747-94,390,693 |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
12 |
P01011 |
chr14: 94,612,377-94,624,055 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
183 |
P01019 |
chr1: 230,702,523-230,714,297 |
A2M |
alpha-2-macroglobulin |
2 |
P01023 |
chr12: 9,067,664-9,116,229 |
C3 |
complement component 3 |
718 |
P01024 |
chr19: 6,677,704-6,730,562 |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
7076 |
P01033 |
chrX: 47,582,313-47,586,789 |
CST3 |
cystatin C |
1471 |
P01034 |
chr20: 23,626,706-23,638,473 |
KNG1 |
kininogen 1 |
3827 |
P01042 |
chr3: 186,717,276-186,743,954 |
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
NGF |
nerve growth factor (beta polypeptide) |
4803 |
P01138 |
chr1: 115,285,918-115,338,236 |
GNRH1 |
gonadotropin releasing hormone 1 |
2796 |
P01148 |
chr8: 25,419,260-25,424,654 |
POMC |
proopiomelanocortin |
5443 |
P01189 |
chr2: 25,160,853-25,168,903 |
PENK |
proenkephalin |
5179 |
P01210 |
chr8: 56,436,674-56,446,734 |
CGA |
glycoprotein hormones, alpha polypeptide |
1081 |
P01215 |
chr6: 87,085,498-87,095,406 |
FSHB |
follicle stimulating hormone, beta polypeptide |
2488 |
P01225 |
chr11: 30,231,016-30,235,261 |
LHB |
luteinizing hormone beta polypeptide |
3972 |
P01229 |
chr19: 49,015,980-49,017,081 |
PRL |
prolactin |
5617 |
P01236 |
chr6: 22,287,244-22,297,501 |
GH1 |
growth hormone 1 |
2688 |
P01241 |
chr17: 63,917,200-63,918,838 |
PTH |
parathyroid hormone |
5741 |
P01270 |
chr11: 13,492,055-13,496,181 |
GCG |
glucagon |
2641 |
P01275 |
chr2: 162,142,873-162,152,404 |
GHRH |
growth hormone releasing hormone |
2691 |
P01286 |
chr20: 37,251,082-37,261,835 |
INS |
insulin |
3630 |
P01308 |
chr11: 2,159,779-2,161,341 |
IGF2 |
insulin like growth factor 2 |
3481 |
P01344 |
chr11: 2,129,112-2,141,238 |
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
IFNA1 |
interferon, alpha 13 |
3447 |
P01562 |
chr9: 21,367,424-21,368,962 |
IL1A |
interleukin 1 alpha |
3552 |
P01583 |
chr2: 112,773,915-112,784,590 |
IL1B |
interleukin 1 beta |
3553 |
P01584 |
chr2: 112,829,751-112,836,903 |
COL1A1 |
collagen, type I, alpha 1 |
1277 |
P02452 |
chr17: 50,183,289-50,201,632 |
COL3A1 |
collagen, type III, alpha 1 |
1281 |
P02461 |
chr2: 188,974,320-189,012,746 |
APOA1 |
apolipoprotein A-I |
335 |
P02647 |
chr11: 116,835,751-116,837,950 |
APOE |
apolipoprotein E |
348 |
P02649 |
chr19: 44,905,754-44,909,393 |
APOA2 |
apolipoprotein A-II |
336 |
P02652 |
chr1: 161,222,292-161,223,631 |
APOC3 |
apolipoprotein C-III |
345 |
P02656 |
chr11: 116,829,706-116,833,072 |
FGA |
fibrinogen alpha chain |
2243 |
P02671 |
chr4: 154,583,126-154,590,766 |
FGB |
fibrinogen beta chain |
2244 |
P02675 |
chr4: 154,562,956-154,571,086 |
FGG |
fibrinogen gamma chain |
2266 |
P02679 |
chr4: 154,604,134-154,612,967 |
CRP |
C-reactive protein, pentraxin-related |
1401 |
P02741 |
chr1: 159,712,289-159,714,589 |
APCS |
amyloid P component, serum |
325 |
P02743 |
chr1: 159,587,825-159,588,865 |
C1QA |
complement component 1, q subcomponent, A chain |
712 |
P02745 |
chr1: 22,636,506-22,639,608 |
APOH |
apolipoprotein H |
350 |
P02749 |
chr17: 66,212,033-66,256,525 |
LRG1 |
leucine-rich alpha-2-glycoprotein 1 |
116844 |
P02750 |
chr19: 4,536,409-4,540,474 |
FN1 |
fibronectin 1 |
2335 |
P02751 |
chr2: 215,360,440-215,436,172 |
RBP4 |
retinol binding protein 4 |
5950 |
P02753 |
chr10: 93,591,687-93,601,744 |
AMBP |
alpha-1-microglobulin/bikunin precursor |
259 |
P02760 |
chr9: 114,060,127-114,078,472 |
ORM1 |
orosomucoid 1 |
5004 |
P02763 |
chr9: 114,323,056-114,326,475 |
AHSG |
alpha-2-HS-glycoprotein |
197 |
P02765 |
chr3: 186,612,923-186,621,318 |
TTR |
transthyretin |
7276 |
P02766 |
chr18: 31,591,726-31,599,021 |
ALB |
albumin |
213 |
P02768 |
chr4: 73,397,114-73,421,412 |
GC |
group-specific component (vitamin D binding protein) |
2638 |
P02774 |
chr4: 71,741,693-71,804,041 |
PPBP |
pro-platelet basic protein |
5473 |
P02775 |
chr4: 73,987,038-73,988,197 |
PF4 |
platelet factor 4 |
5196 |
P02776 |
chr4: 73,981,077-73,982,124 |
TFRC |
transferrin receptor |
7037 |
P02786 |
chr3: 196,027,183-196,082,189 |
TF |
transferrin |
7018 |
P02787 |
chr3: 133,745,956-133,779,006 |
ANG |
angiogenin, ribonuclease, RNase A family, 5 |
283 |
P03950 |
chr14: 20,684,177-20,698,971 |
MMP1 |
matrix metallopeptidase 1 |
4312 |
P03956 |
chr11: 102,789,920-102,798,160 |
AMH |
anti-Mullerian hormone |
268 |
P03971 |
chr19: 2,249,309-2,252,073 |
VTN |
vitronectin |
7448 |
P04004 |
chr17: 28,367,276-28,373,091 |
ALDOA |
aldolase, fructose-bisphosphate A |
226 |
P04075 |
chr16: 30,053,090-30,070,457 |
ANXA1 |
annexin A1 |
301 |
P04083 |
chr9: 73,151,757-73,170,393 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
APOB |
apolipoprotein B |
338 |
P04114 |
chr2: 21,001,429-21,044,073 |
A1BG |
alpha-1-B glycoprotein |
1 |
P04217 |
chr19: 58,345,178-58,353,499 |
S100B |
S100 calcium binding protein B |
6285 |
P04271 |
chr21: 46,598,962-46,605,208 |
VWF |
von Willebrand factor |
7450 |
P04275 |
chr12: 5,948,874-6,124,770 |
SHBG |
sex hormone-binding globulin |
6462 |
P04278 |
chr17: 7,613,946-7,633,383 |
PRB1 |
proline-rich protein BstNI subfamily 1 |
5542 |
P04280 |
chr12: 11,351,823-11,395,566 |
IFNA16 |
interferon, alpha 16 |
3449 |
P05015 |
chr9: 21,216,373-21,217,311 |
IGF1 |
insulin like growth factor 1 |
3479 |
P05019 |
chr12: 102,395,867-102,480,645 |
CHGB |
chromogranin B |
1114 |
P05060 |
chr20: 5,911,430-5,925,361 |
APP |
amyloid beta (A4) precursor protein |
351 |
P05067 |
chr21: 25,880,550-26,171,128 |
APOD |
apolipoprotein D |
347 |
P05090 |
chr3: 195,568,702-195,584,205 |
S100A8 |
S100 calcium binding protein A8 |
6279 |
P05109 |
chr1: 153,390,032-153,391,188 |
INHA |
inhibin alpha |
3623 |
P05111 |
chr2: 219,569,162-219,575,713 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 |
P05121 |
chr7: 101,127,089-101,139,266 |
SERPINA5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
5104 |
P05154 |
chr14: 94,561,442-94,593,120 |
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
710 |
P05155 |
chr11: 57,597,387-57,614,853 |
CFI |
complement factor I |
3426 |
P05156 |
chr4: 109,740,694-109,802,179 |
F13B |
coagulation factor XIII, B polypeptide |
2165 |
P05160 |
chr1: 197,039,191-197,067,267 |
ISG15 |
ISG15 ubiquitin-like modifier |
9636 |
P05161 |
chr1: 1,001,138-1,014,541 |
IL6 |
interleukin 6 |
3569 |
P05231 |
chr7: 22,725,884-22,732,002 |
EDN1 |
endothelin 1 |
1906 |
P05305 |
chr6: 12,290,363-12,297,194 |
SCG5 |
secretogranin V |
6447 |
P05408 |
chr15: 32,641,676-32,697,098 |
CLEC3B |
C-type lectin domain family 3 member B |
7123 |
P05452 |
chr3: 45,001,548-45,036,071 |
COL5A2 |
collagen, type V, alpha 2 |
1290 |
P05997 |
chr2: 189,031,896-189,179,879 |
CCK |
cholecystokinin |
885 |
P06307 |
chr3: 42,257,825-42,266,207 |
S100A9 |
S100 calcium binding protein A9 |
6280 |
P06702 |
chr1: 153,357,854-153,361,027 |
LPL |
lipoprotein lipase |
4023 |
P06858 |
chr8: 19,901,717-19,967,258 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
5270 |
P07093 |
chr2: 223,975,112-224,039,319 |
P4HB |
prolyl 4-hydroxylase, beta polypeptide |
5034 |
P07237 |
chr17: 81,843,159-81,860,694 |
KLK3 |
kallikrein related peptidase 3 |
354 |
P07288 |
chr19: 50,854,915-50,860,764 |
CTSD |
cathepsin D |
1509 |
P07339 |
chr11: 1,752,752-1,764,573 |
C8G |
complement component 8, gamma polypeptide |
733 |
P07360 |
chr9: 136,945,246-136,946,974 |
TUBB |
tubulin beta class I |
203068 |
P07437 |
chr6: 30,720,201-30,725,426 |
PRSS1 |
protease, serine 1 |
5644 |
P07477 |
chr7: 142,749,468-142,753,076 |
DCN |
decorin |
1634 |
P07585 |
chr12: 91,140,484-91,183,123 |
PSAP |
prosaposin |
5660 |
P07602 |
chr10: 71,816,298-71,851,375 |
CTSL |
cathepsin L |
1514 |
P07711 |
chr9: 87,725,519-87,731,393 |
CTSB |
cathepsin B |
1508 |
P07858 |
chr8: 11,842,524-11,869,448 |
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
LAMB1 |
laminin subunit beta 1 |
3912 |
P07942 |
chr7: 107,923,799-108,003,255 |
THBS1 |
thrombospondin 1 |
7057 |
P07996 |
chr15: 39,581,079-39,599,466 |
COL1A2 |
collagen, type I, alpha 2 |
1278 |
P08123 |
chr7: 94,394,561-94,431,232 |
NGFR |
nerve growth factor receptor |
4804 |
P08138 |
chr17: 49,495,293-49,515,017 |
CD55 |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
1604 |
P08174 |
chr1: 207,321,508-207,386,804 |
CELA2B |
chymotrypsin like elastase family member 2B |
51032 |
P08218 |
chr1: 15,465,909-15,491,400 |
MMP2 |
matrix metallopeptidase 2 |
4313 |
P08253 |
chr16: 55,389,700-55,506,691 |
SOD3 |
superoxide dismutase 3, extracellular |
6649 |
P08294 |
chr4: 24,789,912-24,800,842 |
INHBA |
inhibin beta A |
3624 |
P08476 |
chr7: 41,667,168-41,705,834 |
CD14 |
CD14 molecule |
929 |
P08571 |
chr5: 140,631,728-140,633,701 |
COL4A2 |
collagen, type IV, alpha 2 |
1284 |
P08572 |
chr13: 110,305,812-110,513,027 |
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
CFH |
complement factor H |
3075 |
P08603 |
chr1: 196,651,878-196,747,504 |
IGFBP1 |
insulin like growth factor binding protein 1 |
3484 |
P08833 |
chr7: 45,888,357-45,893,668 |
IL6R |
interleukin 6 receptor |
3570 |
P08887 |
chr1: 154,405,193-154,469,450 |
NMB |
neuromedin B |
4828 |
P08949 |
chr15: 84,655,129-84,658,563 |
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
MMP10 |
matrix metallopeptidase 10 |
4319 |
P09238 |
chr11: 102,770,503-102,780,628 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
2919 |
P09341 |
chr4: 73,869,393-73,871,242 |
HMGB1 |
high mobility group box 1 |
3146 |
P09429 |
chr13: 30,456,704-30,617,597 |
PAEP |
progestagen-associated endometrial protein |
5047 |
P09466 |
chr9: 135,561,756-135,566,955 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
6678 |
P09486 |
chr5: 151,661,096-151,687,165 |
INHBB |
inhibin beta B |
3625 |
P09529 |
chr2: 120,346,143-120,351,808 |
WNT2 |
wingless-type MMTV integration site family member 2 |
7472 |
P09544 |
chr7: 117,276,631-117,323,289 |
SCT |
secretin |
6343 |
P09683 |
chr11: 626,431-627,143 |
C1S |
complement component 1, s subcomponent |
716 |
P09871 |
chr12: 6,988,259-7,071,032 |
C4A |
complement component 4A (Rodgers blood group) |
720 |
P0C0L4 |
chr6: 31,982,024-32,002,681 |
C4B |
complement component 4B (Chido blood group) |
721 |
P0C0L5 |
chr6: 32,014,762-32,035,418 |
SAA1 |
serum amyloid A1 |
6288 |
P0DJI8 |
chr11: 18,266,174-18,269,977 |
CGB5 |
chorionic gonadotropin, beta polypeptide 5 |
93659 |
P0DN86 |
chr19: 49,043,884-49,045,311 |
CGB7 |
chorionic gonadotropin, beta polypeptide 7 |
94027 |
P0DN87 |
chr19: 49,054,275-49,058,860 |
SRGN |
serglycin |
5552 |
P10124 |
chr10: 69,088,106-69,104,811 |
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
CCL3 |
chemokine (C-C motif) ligand 3 |
6348 |
P10147 |
chr17: 36,088,256-36,090,169 |
RNASE2 |
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
6036 |
P10153 |
chr14: 20,955,452-20,956,436 |
SPP1 |
secreted phosphoprotein 1 |
6696 |
P10451 |
chr4: 87,975,650-87,983,426 |
C7 |
complement component 7 |
730 |
P10643 |
chr5: 40,909,252-40,982,939 |
TFPI |
tissue factor pathway inhibitor |
7035 |
P10646 |
chr2: 187,464,230-187,565,760 |
CLU |
clusterin |
1191 |
P10909 |
chr8: 27,596,917-27,615,031 |
GHR |
growth hormone receptor |
2690 |
P10912 |
chr5: 42,423,777-42,721,878 |
HAPLN1 |
hyaluronan and proteoglycan link protein 1 |
1404 |
P10915 |
chr5: 83,637,805-83,721,613 |
IAPP |
islet amyloid polypeptide |
3375 |
P10997 |
chr12: 21,354,959-21,379,978 |
LAMC1 |
laminin subunit gamma 1 |
3915 |
P11047 |
chr1: 183,023,460-183,145,592 |
MBL2 |
mannose-binding lectin (protein C) 2, soluble |
4153 |
P11226 |
chr10: 52,765,380-52,771,700 |
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
SFTPC |
surfactant protein C |
6440 |
P11686 |
chr8: 22,156,913-22,164,479 |
COL11A1 |
collagen, type XI, alpha 1 |
1301 |
P12107 |
chr1: 102,876,467-103,108,496 |
COL6A1 |
collagen, type VI, alpha 1 |
1291 |
P12109 |
chr21: 45,981,737-46,005,050 |
COL6A2 |
collagen, type VI, alpha 2 |
1292 |
P12110 |
chr21: 46,098,097-46,132,849 |
COL6A3 |
collagen, type VI, alpha 3 |
1293 |
P12111 |
chr2: 237,324,003-237,414,375 |
F5 |
coagulation factor V (proaccelerin, labile factor) |
2153 |
P12259 |
chr1: 169,514,166-169,586,588 |
PTHLH |
parathyroid hormone-like hormone |
5744 |
P12272 |
chr12: 27,958,084-27,972,705 |
BMP2 |
bone morphogenetic protein 2 |
650 |
P12643 |
chr20: 6,767,664-6,780,280 |
BMP4 |
bone morphogenetic protein 4 |
652 |
P12644 |
chr14: 53,949,736-53,958,761 |
ACTN1 |
actinin, alpha 1 |
87 |
P12814 |
chr14: 68,874,143-68,979,440 |
ACE |
angiotensin I converting enzyme |
1636 |
P12821 |
chr17: 63,477,061-63,498,380 |
DEFA4 |
defensin alpha 4 |
1669 |
P12838 |
chr8: 6,935,822-6,938,338 |
CCL4 |
chemokine (C-C motif) ligand 4 |
6351 |
P13236 |
chr17: 36,103,590-36,105,621 |
BMP1 |
bone morphogenetic protein 1 |
649 |
P13497 |
chr8: 22,164,736-22,212,326 |
CCL2 |
chemokine (C-C motif) ligand 2 |
6347 |
P13500 |
chr17: 34,255,218-34,257,203 |
CCL5 |
chemokine (C-C motif) ligand 5 |
6352 |
P13501 |
chr17: 35,871,491-35,880,793 |
VCAN |
versican |
1462 |
P13611 |
chr5: 83,471,465-83,582,303 |
C6 |
complement component 6 |
729 |
P13671 |
chr5: 41,142,234-41,261,438 |
PRG2 |
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
5553 |
P13727 |
chr11: 57,386,794-57,390,657 |
COL11A2 |
collagen, type XI, alpha 2 |
1302 |
P13942 |
chr6: 33,162,681-33,192,499 |
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
4282 |
P14174 |
chr22: 23,894,004-23,895,227 |
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
3082 |
P14210 |
chr7: 81,699,006-81,770,438 |
NID1 |
nidogen 1 |
4811 |
P14543 |
chr1: 235,975,830-236,065,162 |
PLA2G2A |
phospholipase A2 group IIA |
5320 |
P14555 |
chr1: 19,975,431-19,980,416 |
HSP90B1 |
heat shock protein 90kDa beta family member 1 |
7184 |
P14625 |
chr12: 103,930,107-103,953,645 |
IL1R1 |
interleukin 1 receptor, type I |
3554 |
P14778 |
chr2: 102,064,544-102,179,874 |
MMP9 |
matrix metallopeptidase 9 |
4318 |
P14780 |
chr20: 46,008,908-46,016,561 |
LIF |
leukemia inhibitory factor |
3976 |
P15018 |
chr22: 30,240,447-30,246,851 |
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
7077 |
P16035 |
chr17: 78,852,977-78,925,387 |
PRLR |
prolactin receptor |
5618 |
P16471 |
chr5: 35,048,756-35,230,589 |
NPPB |
natriuretic peptide B |
4879 |
P16860 |
chr1: 11,857,464-11,858,931 |
IL7R |
interleukin 7 receptor |
3575 |
P16871 |
chr5: 35,852,695-35,879,603 |
IGFBP3 |
insulin like growth factor binding protein 3 |
3486 |
P17936 |
chr7: 45,912,245-45,921,874 |
IGFBP2 |
insulin like growth factor binding protein 2 |
3485 |
P18065 |
chr2: 216,632,828-216,664,436 |
EPOR |
erythropoietin receptor |
2057 |
P19235 |
chr19: 11,377,205-11,384,342 |
ORM2 |
orosomucoid 2 |
5005 |
P19652 |
chr9: 114,329,869-114,333,252 |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
2920 |
P19875 |
chr4: 74,097,035-74,099,293 |
FST |
follistatin |
10468 |
P19883 |
chr5: 53,480,409-53,487,134 |
KLK2 |
kallikrein related peptidase 2 |
3817 |
P20151 |
chr19: 50,861,568-50,880,567 |
TNFRSF1B |
tumor necrosis factor receptor superfamily member 1B |
7133 |
P20333 |
chr1: 12,167,003-12,209,228 |
TRH |
thyrotropin-releasing hormone |
7200 |
P20396 |
chr3: 129,974,305-129,977,938 |
OGN |
osteoglycin |
4969 |
P20774 |
chr9: 92,383,967-92,404,696 |
EDN2 |
endothelin 2 |
1907 |
P20800 |
chr1: 41,478,775-41,484,673 |
IL11 |
interleukin 11 |
3589 |
P20809 |
chr19: 55,364,389-55,370,463 |
EFNA1 |
ephrin-A1 |
1942 |
P20827 |
chr1: 155,127,460-155,134,857 |
COL9A1 |
collagen, type IX, alpha 1 |
1297 |
P20849 |
chr6: 70,215,061-70,303,083 |
COL5A1 |
collagen, type V, alpha 1 |
1289 |
P20908 |
chr9: 134,641,774-134,844,843 |
FLNA |
filamin A |
2316 |
P21333 |
chrX: 154,348,524-154,374,638 |
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
MDK |
midkine (neurite growth-promoting factor 2) |
4192 |
P21741 |
chr11: 46,380,756-46,383,837 |
ZP3 |
zona pellucida glycoprotein 3 (sperm receptor) |
7784 |
P21754 |
chr7: 76,397,518-76,442,071 |
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
BGN |
biglycan |
633 |
P21810 |
chrX: 153,494,939-153,509,554 |
GPX3 |
glutathione peroxidase 3 |
2878 |
P22352 |
chr5: 151,020,438-151,028,993 |
GAL |
galanin/GMAP prepropeptide |
51083 |
P22466 |
chr11: 68,683,779-68,691,175 |
IGFBP4 |
insulin like growth factor binding protein 4 |
3487 |
P22692 |
chr17: 40,443,461-40,457,731 |
MMP8 |
matrix metallopeptidase 8 |
4317 |
P22894 |
chr11: 102,711,795-102,727,050 |
FBLN1 |
fibulin 1 |
2192 |
P23142 |
chr22: 45,502,238-45,601,135 |
ANOS1 |
anosmin 1 |
3730 |
P23352 |
chrX: 8,528,874-8,732,186 |
CBLN1 |
cerebellin 1 precursor |
869 |
P23435 |
chr16: 49,277,917-49,281,831 |
BDNF |
brain-derived neurotrophic factor |
627 |
P23560 |
chr11: 27,654,893-27,722,058 |
LAMA2 |
laminin subunit alpha 2 |
3908 |
P24043 |
chr6: 128,883,141-129,516,569 |
MMP11 |
matrix metallopeptidase 11 |
4320 |
P24347 |
chr22: 23,768,226-23,784,316 |
IGFBP6 |
insulin like growth factor binding protein 6 |
3489 |
P24592 |
chr12: 53,097,436-53,102,345 |
IGFBP5 |
insulin like growth factor binding protein 5 |
3488 |
P24593 |
chr2: 216,672,105-216,695,525 |
TNC |
tenascin C |
3371 |
P24821 |
chr9: 115,019,578-115,118,257 |
COL8A2 |
collagen, type VIII, alpha 2 |
1296 |
P25067 |
chr1: 36,095,236-36,125,220 |
F2R |
coagulation factor II (thrombin) receptor |
2149 |
P25116 |
chr5: 76,716,043-76,735,781 |
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
563 |
P25311 |
chr7: 99,966,720-99,976,157 |
CTSS |
cathepsin S |
1520 |
P25774 |
chr1: 150,730,196-150,765,957 |
COL5A3 |
collagen, type V, alpha 3 |
50509 |
P25940 |
chr19: 9,959,561-10,010,471 |
PTX3 |
pentraxin 3 |
5806 |
P26022 |
chr3: 157,436,789-157,443,628 |
CD27 |
CD27 molecule |
939 |
P26842 |
chr12: 6,444,867-6,451,718 |
MST1 |
macrophage stimulating 1 |
4485 |
P26927 |
chr3: 49,683,947-49,689,501 |
PON1 |
paraoxonase 1 |
5444 |
P27169 |
chr7: 95,297,676-95,324,707 |
CALR |
calreticulin |
811 |
P27797 |
chr19: 12,938,578-12,944,489 |
CFP |
complement factor properdin |
5199 |
P27918 |
chrX: 47,623,172-47,630,305 |
IL1R2 |
interleukin 1 receptor, type II |
7850 |
P27930 |
chr2: 101,991,844-102,028,544 |
AOAH |
acyloxyacyl hydrolase |
313 |
P28039 |
chr7: 36,512,949-36,724,549 |
LOX |
lysyl oxidase |
4015 |
P28300 |
chr5: 122,063,195-122,078,360 |
CTGF |
connective tissue growth factor |
1490 |
P29279 |
chr6: 131,948,176-131,951,373 |
EPHA3 |
EPH receptor A3 |
2042 |
P29320 |
chr3: 89,107,524-89,482,134 |
EPHB2 |
EPH receptor B2 |
2048 |
P29323 |
chr1: 22,710,839-22,921,500 |
IL12A |
interleukin 12A |
3592 |
P29459 |
chr3: 159,988,750-159,996,019 |
CASP1 |
caspase 1 |
834 |
P29466 |
chr11: 105,025,443-105,035,250 |
CD6 |
CD6 molecule |
923 |
P30203 |
chr11: 60,971,680-61,020,377 |
LRPAP1 |
LDL receptor related protein associated protein 1 |
4043 |
P30533 |
chr4: 3,506,376-3,532,559 |
NTS |
neurotensin |
4922 |
P30990 |
chr12: 85,874,295-85,882,992 |
S100A7 |
S100 calcium binding protein A7 |
6278 |
P31151 |
chr1: 153,457,744-153,460,701 |
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
GBP1 |
guanylate binding protein 1, interferon-inducible |
2633 |
P32455 |
chr1: 89,052,319-89,065,360 |
RNASE4 |
ribonuclease, RNase A family, 4 |
6038 |
P34096 |
chr14: 20,684,100-20,701,215 |
PRSS3 |
protease, serine 3 |
5646 |
P35030 |
chr9: 33,750,466-33,799,231 |
BTC |
betacellulin |
685 |
P35070 |
chr4: 74,744,759-74,794,686 |
ADM |
adrenomedullin |
133 |
P35318 |
chr11: 10,304,680-10,307,397 |
THBS4 |
thrombospondin 4 |
7060 |
P35443 |
chr5: 79,991,311-80,083,287 |
FBN1 |
fibrillin 1 |
2200 |
P35555 |
chr15: 48,408,306-48,645,849 |
FBN2 |
fibrillin 2 |
2201 |
P35556 |
chr5: 128,257,909-128,659,185 |
ACTN2 |
actinin, alpha 2 |
88 |
P35609 |
chr1: 236,686,454-236,764,631 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
7078 |
P35625 |
chr22: 32,801,701-32,863,043 |
FLT4 |
fms-related tyrosine kinase 4 |
2324 |
P35916 |
chr5: 180,601,506-180,649,624 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
5176 |
P36955 |
chr17: 1,761,959-1,777,574 |
SNCA |
synuclein alpha |
6622 |
P37840 |
chr4: 89,724,099-89,838,315 |
COL15A1 |
collagen, type XV, alpha 1 |
1306 |
P39059 |
chr9: 98,943,179-99,070,792 |
COL18A1 |
collagen, type XVIII, alpha 1 |
80781 |
P39060 |
chr21: 45,405,137-45,513,720 |
PLA2G5 |
phospholipase A2 group V |
5322 |
P39877 |
chr1: 20,028,179-20,091,190 |
IL6ST |
interleukin 6 signal transducer |
3572 |
P40189 |
chr5: 55,935,095-55,994,993 |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
131 |
P40394 |
chr4: 99,412,261-99,435,737 |
PMEL |
premelanosome protein |
6490 |
P40967 |
chr12: 55,954,105-55,973,317 |
LEP |
leptin |
3952 |
P41159 |
chr7: 128,241,284-128,257,628 |
WNT5A |
wingless-type MMTV integration site family member 5A |
7474 |
P41221 |
chr3: 55,465,715-55,490,539 |
PTGDS |
prostaglandin D2 synthase |
5730 |
P41222 |
chr9: 136,975,092-136,981,742 |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
6374 |
P42830 |
chr4: 73,995,642-73,998,779 |
GDF5 |
growth differentiation factor 5 |
8200 |
P43026 |
chr20: 35,433,347-35,454,746 |
PTGFR |
prostaglandin F receptor (FP) |
5737 |
P43088 |
chr1: 78,303,884-78,539,749 |
CTSK |
cathepsin K |
1513 |
P43235 |
chr1: 150,796,208-150,808,323 |
NOTCH1 |
notch 1 |
4851 |
P46531 |
chr9: 136,494,444-136,545,862 |
NPTX2 |
neuronal pentraxin II |
4885 |
P47972 |
chr7: 98,617,297-98,629,868 |
GLIPR1 |
GLI pathogenesis-related 1 |
11010 |
P48060 |
chr12: 75,480,680-75,503,853 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
6387 |
P48061 |
chr10: 44,370,165-44,386,493 |
LEPR |
leptin receptor |
3953 |
P48357 |
chr1: 65,420,652-65,641,559 |
IFNAR2 |
interferon (alpha, beta and omega) receptor 2 |
3455 |
P48551 |
chr21: 33,229,901-33,265,675 |
NMU |
neuromedin U |
10874 |
P48645 |
chr4: 55,595,229-55,636,698 |
CASP4 |
caspase 4 |
837 |
P49662 |
chr11: 104,942,866-104,969,436 |
COMP |
cartilage oligomeric matrix protein |
1311 |
P49747 |
chr19: 18,782,773-18,791,314 |
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
VEGFB |
vascular endothelial growth factor B |
7423 |
P49765 |
chr11: 64,234,538-64,238,793 |
VEGFC |
vascular endothelial growth factor C |
7424 |
P49767 |
chr4: 176,683,538-176,792,727 |
SEPP1 |
selenoprotein P, plasma, 1 |
6414 |
P49908 |
chr5: 42,799,880-42,887,392 |
AGTR2 |
angiotensin II receptor, type 2 |
186 |
P50052 |
chrX: 116,170,722-116,174,972 |
TNFSF10 |
tumor necrosis factor superfamily member 10 |
8743 |
P50591 |
chr3: 172,505,508-172,523,507 |
PPT1 |
palmitoyl-protein thioesterase 1 |
5538 |
P50897 |
chr1: 40,071,461-40,097,727 |
INSL3 |
insulin like 3 |
3640 |
P51460 |
chr19: 17,816,512-17,821,574 |
LUM |
lumican |
4060 |
P51884 |
chr12: 91,102,629-91,111,831 |
EFNA4 |
ephrin-A4 |
1945 |
P52798 |
chr1: 155,063,731-155,069,553 |
EFNA5 |
ephrin-A5 |
1946 |
P52803 |
chr5: 107,376,889-107,670,895 |
CAPZA1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
829 |
P52907 |
chr1: 112,619,173-112,671,619 |
CRISP3 |
cysteine-rich secretory protein 3 |
10321 |
P54108 |
chr6: 49,727,384-49,744,437 |
EPHB4 |
EPH receptor B4 |
2050 |
P54760 |
chr7: 100,802,565-100,827,521 |
EPHB1 |
EPH receptor B1 |
2047 |
P54762 |
chr3: 134,597,801-135,260,467 |
MFAP2 |
microfibrillar associated protein 2 |
4237 |
P55001 |
chr1: 16,974,502-16,980,835 |
MFAP3 |
microfibrillar associated protein 3 |
4238 |
P55082 |
chr5: 154,038,906-154,220,478 |
INHBC |
inhibin beta C |
3626 |
P55103 |
chr12: 57,434,760-57,450,828 |
GFER |
growth factor, augmenter of liver regeneration |
2671 |
P55789 |
chr16: 1,984,207-1,987,749 |
WNT3 |
wingless-type MMTV integration site family member 3 |
7473 |
P56703 |
chr17: 46,762,506-46,833,154 |
ANTXR2 |
anthrax toxin receptor 2 |
118429 |
P58335 |
chr4: 79,901,149-80,125,454 |
NXPH1 |
neurexophilin 1 |
30010 |
P58417 |
chr7: 8,433,955-8,752,963 |
PTEN |
phosphatase and tensin homolog |
5728 |
P60484 |
chr10: 87,863,113-87,971,930 |
ZP1 |
zona pellucida glycoprotein 1 |
22917 |
P60852 |
chr11: 60,867,562-60,875,693 |
LYZ |
lysozyme |
4069 |
P61626 |
chr12: 69,348,341-69,354,234 |
B2M |
beta-2-microglobulin |
567 |
P61769 |
chr15: 44,711,477-44,718,877 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
CALM2 |
calmodulin 2 |
805 |
P62158 |
chr2: 47,160,082-47,176,601 |
TMSB4X |
thymosin beta 4, X-linked |
7114 |
P62328 |
chrX: 12,975,108-12,977,227 |
HIST1H4A |
histone cluster 1, H4d |
8360 |
P62805 |
chr6: 26,188,765-26,189,076 |
PPIA |
peptidylprolyl isomerase A (cyclophilin A) |
5478 |
P62937 |
chr7: 44,796,680-44,824,564 |
TUBA4A |
tubulin alpha 4a |
7277 |
P68366 |
chr2: 219,249,711-219,278,170 |
HIST1H3D |
histone cluster 1 H3 family member d |
8351 |
P68431 |
chr6: 26,195,595-26,199,293 |
HBB |
hemoglobin subunit beta |
3043 |
P68871 |
chr11: 5,225,464-5,229,395 |
HBA1 |
hemoglobin subunit alpha 1 |
3039 |
P69905 |
chr16: 176,680-177,522 |
CXADR |
coxsackie virus and adenovirus receptor |
1525 |
P78310 |
chr21: 17,512,382-17,593,579 |
JAG1 |
jagged 1 |
182 |
P78504 |
chr20: 10,637,684-10,674,107 |
CCL20 |
chemokine (C-C motif) ligand 20 |
6364 |
P78556 |
chr2: 227,813,842-227,817,564 |
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
6372 |
P80162 |
chr4: 73,836,497-73,849,064 |
LCN2 |
lipocalin 2 |
3934 |
P80188 |
chr9: 128,149,071-128,153,455 |
HAMP |
hepcidin antimicrobial peptide |
57817 |
P81172 |
chr19: 35,280,716-35,285,143 |
CRB1 |
crumbs family member 1, photoreceptor morphogenesis associated |
23418 |
P82279 |
chr1: 197,268,204-197,478,455 |
HTRA3 |
HtrA serine peptidase 3 |
94031 |
P83110 |
chr4: 8,269,765-8,307,111 |
H3F3A |
H3 histone, family 3A |
3020 |
P84243 |
chr1: 226,061,851-226,072,001 |
FBLN2 |
fibulin 2 |
2199 |
P98095 |
chr3: 13,549,131-13,638,422 |
HSPG2 |
heparan sulfate proteoglycan 2 |
3339 |
P98160 |
chr1: 21,822,245-21,937,297 |
IL9R |
interleukin 9 receptor |
3581 |
Q01113 |
chrX: 155,997,581-156,010,817 |
COL4A3 |
collagen, type IV, alpha 3 (Goodpasture antigen) |
1285 |
Q01955 |
chr2: 227,164,565-227,314,792 |
NRG1 |
neuregulin 1 |
3084 |
Q02297 |
chr8: 31,639,386-32,767,959 |
MUC3A |
mucin 3A, cell surface associated |
4584 |
Q02505 |
chr7: 100,949,555-100,968,346 |
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
COL10A1 |
collagen, type X, alpha 1 |
1300 |
Q03692 |
chr6: 116,118,923-116,158,747 |
NOTCH2 |
notch 2 |
4853 |
Q04721 |
chr1: 119,911,553-120,069,626 |
CD164 |
CD164 molecule, sialomucin |
8763 |
Q04900 |
chr6: 109,366,514-109,382,457 |
COL14A1 |
collagen, type XIV, alpha 1 |
7373 |
Q05707 |
chr8: 120,059,780-120,372,036 |
FMOD |
fibromodulin |
2331 |
Q06828 |
chr1: 203,340,628-203,351,489 |
COL16A1 |
collagen, type XVI, alpha 1 |
1307 |
Q07092 |
chr1: 31,652,247-31,704,319 |
LOXL1 |
lysyl oxidase like 1 |
4016 |
Q08397 |
chr15: 73,925,989-73,952,137 |
MFGE8 |
milk fat globule-EGF factor 8 protein |
4240 |
Q08431 |
chr15: 88,898,683-88,913,411 |
GALNT1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
2589 |
Q10472 |
chr18: 35,581,117-35,711,834 |
ST3GAL3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
6487 |
Q11203 |
chr1: 43,705,824-43,931,165 |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
2202 |
Q12805 |
chr2: 55,865,967-55,924,139 |
FSTL1 |
follistatin like 1 |
11167 |
Q12841 |
chr3: 120,392,293-120,451,253 |
PSG7 |
pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) |
5676 |
Q13046 |
chr19: 42,924,132-42,937,178 |
PLA2G7 |
phospholipase A2 group VII |
7941 |
Q13093 |
chr6: 46,704,201-46,735,693 |
SPP2 |
secreted phosphoprotein 2 |
6694 |
Q13103 |
chr2: 234,050,679-234,077,134 |
MMRN1 |
multimerin 1 |
22915 |
Q13201 |
chr4: 89,879,532-89,954,629 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
5069 |
Q13219 |
chr9: 116,153,804-116,402,322 |
CHIT1 |
chitinase 1 |
1118 |
Q13231 |
chr1: 203,212,827-203,273,641 |
MFAP5 |
microfibrillar associated protein 5 |
8076 |
Q13361 |
chr12: 8,637,346-8,662,888 |
COL4A6 |
collagen, type IV, alpha 6 |
1288 |
Q14031 |
chrX: 108,155,607-108,439,497 |
NID2 |
nidogen 2 |
22795 |
Q14112 |
chr14: 52,004,803-52,069,228 |
IL18 |
interleukin 18 |
3606 |
Q14116 |
chr11: 112,143,251-112,164,117 |
DAG1 |
dystroglycan 1 |
1605 |
Q14118 |
chr3: 49,468,703-49,535,618 |
GAS6 |
growth arrest specific 6 |
2621 |
Q14393 |
chr13: 113,820,549-113,864,067 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
10371 |
Q14563 |
chr7: 83,955,777-84,492,724 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
4052 |
Q14766 |
chr2: 32,946,972-33,399,509 |
KARS |
lysyl-tRNA synthetase |
3735 |
Q15046 |
chr16: 75,627,474-75,648,643 |
NECTIN1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
5818 |
Q15223 |
chr11: 119,623,408-119,729,084 |
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
ANGPT1 |
angiopoietin 1 |
284 |
Q15389 |
chr8: 107,249,482-107,498,055 |
FCN2 |
ficolin 2 |
2220 |
Q15485 |
chr9: 134,880,812-134,887,520 |
RGN |
regucalcin |
9104 |
Q15493 |
chrX: 47,078,355-47,093,314 |
TGFBI |
transforming growth factor beta induced |
7045 |
Q15582 |
chr5: 136,028,895-136,063,818 |
KISS1 |
KiSS-1 metastasis-suppressor |
3814 |
Q15726 |
chr1: 204,190,341-204,196,486 |
CLUL1 |
clusterin like 1 |
27098 |
Q15846 |
chr18: 596,988-650,334 |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
9370 |
Q15848 |
chr3: 186,842,690-186,858,463 |
IGFBP7 |
insulin like growth factor binding protein 7 |
3490 |
Q16270 |
chr4: 57,030,773-57,110,385 |
LAMA4 |
laminin subunit alpha 4 |
3910 |
Q16363 |
chr6: 112,108,760-112,254,939 |
PSG3 |
pregnancy specific beta-1-glycoprotein 3 |
5671 |
Q16557 |
chr19: 42,721,638-42,740,569 |
CTF1 |
cardiotrophin 1 |
1489 |
Q16619 |
chr16: 30,896,607-30,903,560 |
LAMA3 |
laminin subunit alpha 3 |
3909 |
Q16787 |
chr18: 23,689,443-23,955,066 |
ST3GAL2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
6483 |
Q16842 |
chr16: 70,375,978-70,439,237 |
MST1L |
macrophage stimulating 1-like |
11223 |
Q2TV78 |
chr1: 16,754,910-16,770,237 |
MMEL1 |
membrane metallo-endopeptidase-like 1 |
79258 |
Q495T6 |
chr1: 2,590,639-2,632,990 |
BOLA3 |
bolA family member 3 |
388962 |
Q53S33 |
chr2: 74,135,398-74,147,994 |
PDZD11 |
PDZ domain containing 11 |
51248 |
Q5EBL8 |
chrX: 70,286,595-70,290,514 |
HABP4 |
hyaluronan binding protein 4 |
22927 |
Q5JVS0 |
chr9: 96,450,201-96,491,336 |
COL13A1 |
collagen, type XIII, alpha 1 |
1305 |
Q5TAT6 |
chr10: 69,801,931-69,964,275 |
ABHD17B |
abhydrolase domain containing 17B |
51104 |
Q5VST6 |
chr9: 71,862,452-71,910,931 |
SUSD4 |
sushi domain containing 4 |
55061 |
Q5VX71 |
chr1: 223,220,819-223,364,202 |
OLFML2B |
olfactomedin like 2B |
25903 |
Q68BL8 |
chr1: 161,983,192-162,023,854 |
C12orf73 |
chromosome 12 open reading frame 73 |
728568 |
Q69YU5 |
chr12: 103,950,202-103,965,708 |
CTRB2 |
chymotrypsinogen B2 |
440387 |
Q6GPI1 |
chr16: 75,204,096-75,207,185 |
LAIR2 |
leukocyte-associated immunoglobulin-like receptor 2 |
3904 |
Q6ISS4 |
chr19: 54,497,879-54,510,687 |
APOA5 |
apolipoprotein A-V |
116519 |
Q6Q788 |
chr11: 116,789,367-116,792,420 |
CSPG4 |
chondroitin sulfate proteoglycan 4 |
1464 |
Q6UVK1 |
chr15: 75,674,322-75,712,848 |
ENHO |
energy homeostasis associated |
375704 |
Q6UWT2 |
chr9: 34,521,040-34,523,041 |
ARSK |
arylsulfatase family member K |
153642 |
Q6UWY0 |
chr5: 95,555,074-95,605,064 |
DHRS13 |
dehydrogenase/reductase (SDR family) member 13 |
147015 |
Q6UX07 |
chr17: 28,897,781-28,903,071 |
FAM150B |
family with sequence similarity 150 member B |
285016 |
Q6UX46 |
chr2: 279,558-288,851 |
FAM131A |
family with sequence similarity 131 member A |
131408 |
Q6UXB0 |
chr3: 184,335,926-184,348,421 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
25891 |
Q6UXH9 |
chr11: 35,431,823-35,530,300 |
IL34 |
interleukin 34 |
146433 |
Q6ZMJ4 |
chr16: 70,579,895-70,660,682 |
NOTCH2NL |
notch 2 N-terminal like |
388677 |
Q7Z3S9 |
chr1: 146,146,203-146,229,026 |
FAM19A5 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
25817 |
Q7Z5A7 |
chr22: 48,489,460-48,850,912 |
LYG2 |
lysozyme G-like 2 |
254773 |
Q86SG7 |
chr2: 99,242,246-99,255,282 |
C6orf1 |
chromosome 6 open reading frame 1 |
221491 |
Q86T20 |
chr6: 34,246,380-34,249,470 |
ITIH5 |
inter-alpha-trypsin inhibitor heavy chain family member 5 |
80760 |
Q86UX2 |
chr10: 7,559,270-7,666,998 |
VASH2 |
vasohibin 2 |
79805 |
Q86V25 |
chr1: 212,950,520-212,992,037 |
CD163 |
CD163 molecule |
9332 |
Q86VB7 |
chr12: 7,470,813-7,503,893 |
CHSY1 |
chondroitin sulfate synthase 1 |
22856 |
Q86X52 |
chr15: 101,175,723-101,251,932 |
WFDC3 |
WAP four-disulfide core domain 3 |
140686 |
Q8IUB2 |
chr20: 45,747,944-45,791,932 |
VSTM4 |
V-set and transmembrane domain containing 4 |
196740 |
Q8IW00 |
chr10: 49,014,245-49,115,509 |
GLB1L2 |
galactosidase beta 1 like 2 |
89944 |
Q8IW92 |
chr11: 134,331,874-134,378,341 |
CNTN4 |
contactin 4 |
152330 |
Q8IWV2 |
chr3: 2,098,813-3,057,956 |
SCUBE3 |
signal peptide, CUB domain, EGF-like 3 |
222663 |
Q8IX30 |
chr6: 35,214,419-35,253,079 |
LAS2 |
lung adenoma susceptibility protein 2 |
162681 |
Q8IYD9 |
chr18: 54,357,917-54,385,218 |
LYPD1 |
LY6/PLAUR domain containing 1 |
116372 |
Q8N2G4 |
chr2: 132,644,853-132,671,579 |
AGGF1 |
angiogenic factor with G-patch and FHA domains 1 |
55109 |
Q8N302 |
chr5: 77,029,251-77,065,234 |
MUC20 |
mucin 20, cell surface associated |
200958 |
Q8N307 |
chr3: 195,720,882-195,741,123 |
MUC15 |
mucin 15, cell surface associated |
143662 |
Q8N387 |
chr11: 26,559,033-26,572,233 |
PRSS35 |
protease, serine 35 |
167681 |
Q8N3Z0 |
chr6: 83,512,538-83,525,704 |
SFRP1 |
secreted frizzled-related protein 1 |
6422 |
Q8N474 |
chr8: 41,261,958-41,309,497 |
C2orf69 |
chromosome 2 open reading frame 69 |
205327 |
Q8N8R5 |
chr2: 199,911,256-199,955,935 |
HSD17B11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
51170 |
Q8NBQ5 |
chr4: 87,336,610-87,391,386 |
NPB |
neuropeptide B |
256933 |
Q8NG41 |
chr17: 81,900,745-81,902,905 |
LILRB1 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 |
Q8NHL6 |
chr19: 54,617,158-54,637,528 |
FIBIN |
fin bud initiation factor homolog (zebrafish) |
387758 |
Q8TAL6 |
chr11: 26,994,184-26,996,121 |
SPATA20 |
spermatogenesis associated 20 |
64847 |
Q8TB22 |
chr17: 50,543,058-50,555,852 |
NDNF |
neuron-derived neurotrophic factor |
79625 |
Q8TB73 |
chr4: 121,035,613-121,073,021 |
BPIFB1 |
BPI fold containing family B member 1 |
92747 |
Q8TDL5 |
chr20: 33,273,480-33,309,878 |
DEFB104A |
defensin beta 104B |
503618 |
Q8WTQ1 |
chr8: 7,470,308-7,475,082 |
CYB5D2 |
cytochrome b5 domain containing 2 |
124936 |
Q8WUJ1 |
chr17: 4,143,168-4,187,310 |
CEMIP |
cell migration inducing protein, hyaluronan binding |
57214 |
Q8WUJ3 |
chr15: 80,779,343-80,951,776 |
C1orf54 |
chromosome 1 open reading frame 54 |
79630 |
Q8WWF1 |
chr1: 150,268,200-150,280,916 |
TTN |
titin |
7273 |
Q8WZ42 |
chr2: 178,525,989-178,830,802 |
FAM3C |
family with sequence similarity 3 member C |
10447 |
Q92520 |
chr7: 121,348,851-121,396,364 |
HSPH1 |
heat shock protein family H (Hsp110) member 1 |
10808 |
Q92598 |
chr13: 31,134,974-31,162,388 |
ESR2 |
estrogen receptor 2 (ER beta) |
2100 |
Q92731 |
chr14: 64,084,232-64,338,112 |
HTRA1 |
HtrA serine peptidase 1 |
5654 |
Q92743 |
chr10: 122,461,525-122,514,908 |
TNR |
tenascin R |
7143 |
Q92752 |
chr1: 175,315,194-175,743,770 |
NRCAM |
neuronal cell adhesion molecule |
4897 |
Q92823 |
chr7: 108,147,623-108,456,717 |
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
PRG4 |
proteoglycan 4 |
10216 |
Q92954 |
chr1: 186,296,279-186,314,562 |
TNFRSF25 |
tumor necrosis factor receptor superfamily member 25 |
8718 |
Q93038 |
chr1: 6,461,151-6,466,195 |
WNT2B |
wingless-type MMTV integration site family member 2B |
7482 |
Q93097 |
chr1: 112,466,541-112,530,165 |
MR1 |
major histocompatibility complex, class I-related |
3140 |
Q95460 |
chr1: 181,033,425-181,061,938 |
VWCE |
von Willebrand factor C and EGF domains |
220001 |
Q96DN2 |
chr11: 61,258,286-61,295,424 |
MUCL1 |
mucin-like 1 |
118430 |
Q96DR8 |
chr12: 54,830,519-54,858,393 |
RSPRY1 |
ring finger and SPRY domain containing 1 |
89970 |
Q96DX4 |
chr16: 57,186,137-57,240,475 |
BCAN |
brevican |
63827 |
Q96GW7 |
chr1: 156,641,390-156,659,532 |
APOLD1 |
apolipoprotein L domain containing 1 |
81575 |
Q96LR9 |
chr12: 12,725,917-12,829,975 |
GLT1D1 |
glycosyltransferase 1 domain containing 1 |
144423 |
Q96MS3 |
chr12: 128,853,427-128,984,968 |
VSTM2L |
V-set and transmembrane domain containing 2 like |
128434 |
Q96N03 |
chr20: 37,903,104-37,945,350 |
COL21A1 |
collagen, type XXI, alpha 1 |
81578 |
Q96P44 |
chr6: 56,056,590-56,394,094 |
HHIP |
hedgehog interacting protein |
64399 |
Q96QV1 |
chr4: 144,646,021-144,745,271 |
GPX7 |
glutathione peroxidase 7 |
2882 |
Q96SL4 |
chr1: 52,602,372-52,609,051 |
CSF3R |
colony stimulating factor 3 receptor |
1441 |
Q99062 |
chr1: 36,466,043-36,483,278 |
HBEGF |
heparin-binding EGF-like growth factor |
1839 |
Q99075 |
chr5: 140,332,843-140,346,631 |
NELL2 |
neural EGFL like 2 |
4753 |
Q99435 |
chr12: 44,508,275-44,921,848 |
PLIN2 |
perilipin 2 |
123 |
Q99541 |
chr9: 19,108,375-19,149,290 |
MMP19 |
matrix metallopeptidase 19 |
4327 |
Q99542 |
chr12: 55,835,433-55,842,966 |
COL12A1 |
collagen, type XII, alpha 1 |
1303 |
Q99715 |
chr6: 75,084,326-75,206,051 |
PROL1 |
proline rich, lacrimal 1 |
58503 |
Q99935 |
chr4: 70,397,882-70,410,194 |
EGFL8 |
EGF-like-domain, multiple 8 |
80864 |
Q99944 |
chr6: 32,164,583-32,168,281 |
RARRES2 |
retinoic acid receptor responder (tazarotene induced) 2 |
5919 |
Q99969 |
chr7: 150,338,317-150,341,674 |
OMD |
osteomodulin |
4958 |
Q99983 |
chr9: 92,414,245-92,424,461 |
GDF15 |
growth differentiation factor 15 |
9518 |
Q99988 |
chr19: 18,374,731-18,389,176 |
SOST |
sclerostin |
50964 |
Q9BQB4 |
chr17: 43,753,731-43,758,788 |
APOL2 |
apolipoprotein L2 |
23780 |
Q9BQE5 |
chr22: 36,226,203-36,239,954 |
CCDC3 |
coiled-coil domain containing 3 |
83643 |
Q9BQI4 |
chr10: 12,896,625-13,099,652 |
PRADC1 |
protease-associated domain containing 1 |
84279 |
Q9BSG0 |
chr2: 73,228,006-73,233,238 |
NDFIP1 |
Nedd4 family interacting protein 1 |
80762 |
Q9BT67 |
chr5: 142,108,505-142,154,443 |
MENT |
methylated in normal thymocytes protein |
54964 |
Q9BUN1 |
chr1: 151,047,740-151,051,986 |
APOO |
apolipoprotein O |
79135 |
Q9BUR5 |
chrX: 23,833,353-23,907,934 |
C1QTNF7 |
C1q and tumor necrosis factor related protein 7 |
114905 |
Q9BXJ2 |
chr4: 15,339,818-15,446,166 |
EMILIN2 |
elastin microfibril interfacer 2 |
84034 |
Q9BXX0 |
chr18: 2,847,030-2,915,993 |
RSPO3 |
R-spondin 3 |
84870 |
Q9BXY4 |
chr6: 127,118,604-127,197,765 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
55075 |
Q9BZF9 |
chr15: 70,654,554-70,763,593 |
PLA2G12A |
phospholipase A2 group XIIA |
81579 |
Q9BZM1 |
chr4: 109,709,989-109,730,077 |
SIGLEC1 |
sialic acid binding Ig-like lectin 1, sialoadhesin |
6614 |
Q9BZZ2 |
chr20: 3,686,970-3,707,128 |
TINAGL1 |
tubulointerstitial nephritis antigen-like 1 |
64129 |
Q9GZM7 |
chr1: 31,576,485-31,587,686 |
PDGFD |
platelet derived growth factor D |
80310 |
Q9GZP0 |
chr11: 103,907,186-104,164,379 |
WNT5B |
wingless-type MMTV integration site family member 5B |
81029 |
Q9H1J7 |
chr12: 1,529,891-1,647,243 |
CXCL16 |
chemokine (C-X-C motif) ligand 16 |
58191 |
Q9H2A7 |
chr17: 4,733,526-4,739,922 |
GREM2 |
gremlin 2, DAN family BMP antagonist |
64388 |
Q9H772 |
chr1: 240,489,573-240,612,149 |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
54210 |
Q9NP99 |
chr6: 41,267,926-41,286,719 |
NGRN |
neugrin, neurite outgrowth associated |
51335 |
Q9NPE2 |
chr15: 90,265,659-90,278,141 |
IL1RAP |
interleukin 1 receptor accessory protein |
3556 |
Q9NPH3 |
chr3: 190,514,051-190,659,750 |
ESM1 |
endothelial cell-specific molecule 1 |
11082 |
Q9NQ30 |
chr5: 54,977,864-55,022,671 |
CD163L1 |
CD163 molecule like 1 |
283316 |
Q9NR16 |
chr12: 7,346,685-7,479,897 |
PDGFC |
platelet derived growth factor C |
56034 |
Q9NRA1 |
chr4: 156,760,454-156,971,394 |
IL17RB |
interleukin 17 receptor B |
55540 |
Q9NRM6 |
chr3: 53,846,580-53,865,800 |
LTBP3 |
latent transforming growth factor beta binding protein 3 |
4054 |
Q9NS15 |
chr11: 65,538,805-65,558,930 |
ERAP1 |
endoplasmic reticulum aminopeptidase 1 |
51752 |
Q9NZ08 |
chr5: 96,760,810-96,808,100 |
IL37 |
interleukin 37 |
27178 |
Q9NZH6 |
chr2: 112,912,971-112,918,882 |
DSPP |
dentin sialophosphoprotein |
1834 |
Q9NZW4 |
chr4: 87,608,529-87,616,910 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
23529 |
Q9UBD9 |
chr11: 67,364,168-67,374,177 |
CKLF |
chemokine-like factor |
51192 |
Q9UBR5 |
chr16: 66,552,563-66,566,251 |
GABBR1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
2550 |
Q9UBS5 |
chr6: 29,555,629-29,633,976 |
GHRL |
ghrelin/obestatin prepropeptide |
51738 |
Q9UBU3 |
chr3: 10,285,675-10,292,947 |
KL |
klotho |
9365 |
Q9UEF7 |
chr13: 33,016,433-33,066,145 |
FAM198A |
family with sequence similarity 198 member A |
729085 |
Q9UFP1 |
chr3: 42,979,267-43,060,211 |
DMBT1 |
deleted in malignant brain tumors 1 |
1755 |
Q9UGM3 |
chr10: 122,560,665-122,643,736 |
FETUB |
fetuin B |
26998 |
Q9UGM5 |
chr3: 186,635,969-186,653,141 |
TMEFF2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
23671 |
Q9UIK5 |
chr2: 191,949,043-192,195,709 |
LNPEP |
leucyl/cystinyl aminopeptidase |
4012 |
Q9UIQ6 |
chr5: 96,935,394-97,037,515 |
ENPP5 |
ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) |
59084 |
Q9UJA9 |
chr6: 46,159,187-46,170,971 |
HEG1 |
heart development protein with EGF-like domains 1 |
57493 |
Q9ULI3 |
chr3: 124,965,710-125,055,958 |
APLN |
apelin |
8862 |
Q9ULZ1 |
chrX: 129,645,259-129,654,937 |
PYCARD |
PYD and CARD domain containing |
29108 |
Q9ULZ3 |
chr16: 31,201,485-31,203,450 |
COL17A1 |
collagen, type XVII, alpha 1 |
1308 |
Q9UMD9 |
chr10: 104,031,286-104,086,002 |
PCDHA6 |
protocadherin alpha 6 |
56142 |
Q9UN73 |
chr5: 140,827,958-141,012,344 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif 5 |
11096 |
Q9UNA0 |
chr21: 26,917,912-26,966,513 |
PROCR |
protein C receptor |
10544 |
Q9UNN8 |
chr20: 35,172,073-35,216,240 |
TNFSF13B |
tumor necrosis factor superfamily member 13b |
10673 |
Q9Y275 |
chr13: 108,251,240-108,308,484 |
ITM2B |
integral membrane protein 2B |
9445 |
Q9Y287 |
chr13: 48,233,158-48,270,357 |
BOLA1 |
bolA family member 1 |
51027 |
Q9Y3E2 |
chr1: 149,887,890-149,900,798 |
C2CD2 |
C2 calcium-dependent domain containing 2 |
25966 |
Q9Y426 |
chr21: 41,885,112-41,953,890 |
TLN1 |
talin 1 |
7094 |
Q9Y490 |
chr9: 35,696,948-35,732,395 |
HYOU1 |
hypoxia up-regulated 1 |
10525 |
Q9Y4L1 |
chr11: 119,044,189-119,057,202 |
PCDHA10 |
protocadherin alpha 10 |
56139 |
Q9Y5I2 |
chr5: 140,855,883-141,012,344 |
PCDHA1 |
protocadherin alpha 1 |
56147 |
Q9Y5I3 |
chr5: 140,786,136-141,012,347 |
WIF1 |
WNT inhibitory factor 1 |
11197 |
Q9Y5W5 |
chr12: 65,050,626-65,121,566 |
LIPG |
lipase, endothelial |
9388 |
Q9Y5X9 |
chr18: 49,560,699-49,599,182 |
WNT6 |
wingless-type MMTV integration site family member 6 |
7475 |
Q9Y6F9 |
chr2: 218,859,821-218,874,233 |
LAMC3 |
laminin subunit gamma 3 |
10319 |
Q9Y6N6 |
chr9: 131,009,082-131,094,473 |